GSK Raises Prospects For Withdrawn Blood Cancer Drug Blenrep To Return To US Market - Here's Why
On Thursday, GSK plc (NYSE:GSK) released headline results from a planned interim analysis of the DREAMM-7 head-to-head phase ...
GSK’s Withdrawn Blood Cancer Drug Reduced Risk of Death in Trial
GSK Plc said its blood cancer drug significantly reduced the risk of death when combined with another cancer treatment, ...
GSK’s Withdrawn Blood Cancer Drug Paves Path Back to Market
GSK Plc said its blood cancer drug significantly reduced the risk of death when combined with another cancer treatment, ...
Bloomberg L.P.2d
GSK Steps Up Parkinson’s Focus With US Biotech Deal
GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...
GSK Reports Positive Headline Results From DREAMM-7 Phase III Trial
GSK plc (GSK, GSK.L), on Thursday, announced positive headline results from a planned interim analysis of the DREAMM-7 head-to-head ...
Pharmabiz14h
GSK-sponsored survey reveals unique gaps in care and support facing patients with gynaecologic cancers
GSK plc announced the results of a GSK-sponsored multinational survey designed to raise awareness of challenges that people with gynaecologic cancers may experience. The survey, which was conducted by ...
Global Dermatological Drugs Market to Cross USD 31 Billion by 2030 | DelveInsight
DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...
Yahoo Finance1d
Kahn Brothers' Strategic Exits and Acquisitions in Q3 2024: Spotlight on MBIA Inc
Chevron Corp (NYSE:CVX), with all 1,800 shares liquidated, causing a -0.05% impact on the portfolio. GSK PLC (NYSE:GSK) by ...
£10 a day invested in UK shares could one day create a second income of over £3,000 a month!
Mark David Hartley outlines a strategy he’d use to aim for a second income that gets bigger over time, by investing just £10 ...